Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine.
NAFLD
premenopausal syndrome
steatosis
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
20 05 2022
20 05 2022
Historique:
received:
28
04
2022
revised:
18
05
2022
accepted:
19
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that affects 25% of the world's population. There is a clear difference in both geographical distribution and sex in childbearing age. These differences are reduced when women become older and senescence begins. The factors that affect the likelihood of developing NAFLD in a premenopausal woman are an imbalance of sex hormones (especially in estradiol and androgen), microbiome dysregulation, insulin resistance, early menarche, the length of time that the woman breastfeeds for and polycystic ovarian syndrome (PCOS). The aim of this review is to identify various physical ailments that may not appear to be serious to young women but that then affect the onset of NAFLD in perimenopause and can degenerate into NASH. These conditions should also be considered in future clinical management, as well as in research opportunities, in order to customize the monitoring and treatment of NAFLD, considering gender medicine for those women who had early metabolic symptoms that were not considered to be significant at the time.
Identifiants
pubmed: 35625920
pii: biomedicines10051184
doi: 10.3390/biomedicines10051184
pmc: PMC9138606
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Italian Ministry of Health
ID : No number of grant. these grant are assigned every year at the Institute
Références
Liver Int. 2016 Feb;36(2):268-74
pubmed: 26114995
Biomedicines. 2022 Jan 07;10(1):
pubmed: 35052811
Am J Gastroenterol. 2017 May;112(5):755-762
pubmed: 28291240
Cell Metab. 2017 Mar 7;25(3):499-505
pubmed: 28190772
J Pediatr Endocrinol Metab. 2021 Apr 07;34(5):607-612
pubmed: 33823088
BMC Med. 2017 Feb 28;15(1):45
pubmed: 28241825
Steroids. 2017 May;121:17-21
pubmed: 28288896
PLoS Med. 2018 Mar 28;15(3):e1002542
pubmed: 29590099
Cell Mol Immunol. 2016 May;13(3):267-76
pubmed: 27063467
J Hepatol. 2007 Sep;47(3):412-7
pubmed: 17560682
PLoS One. 2022 Feb 2;17(2):e0262855
pubmed: 35108315
Eur J Endocrinol. 2015 Dec;173(6):739-47
pubmed: 26340970
J Clin Endocrinol Metab. 1991 Nov;73(5):1099-105
pubmed: 1939525
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Hepatology. 2019 Jun;69(6):2672-2682
pubmed: 30179269
Maturitas. 2018 Oct;116:1-7
pubmed: 30244768
Front Reprod Health. 2021 Dec 03;3:792920
pubmed: 36303965
Medicine (Baltimore). 2020 Jan;99(2):e18440
pubmed: 31914017
Clin Chim Acta. 2021 Dec;523:304-314
pubmed: 34666025
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Nat Rev Gastroenterol Hepatol. 2013 May;10(5):307-18
pubmed: 23458891
FASEB J. 2005 Aug;19(10):1266-71
pubmed: 16051693
Menopause. 2009 Jul-Aug;16(4):708-18
pubmed: 19322116
Dig Liver Dis. 2009 Feb;41(2):150-5
pubmed: 18448398
Clin Gastroenterol Hepatol. 2017 Jan;15(1):127-131.e2
pubmed: 27523635
Cells. 2021 Sep 21;10(9):
pubmed: 34572151
Endocr Rev. 1995 Jun;16(3):271-321
pubmed: 7671849
J Clin Endocrinol Metab. 1996 Jul;81(7):2460-7
pubmed: 8675561
J Clin Cell Immunol. 2017 Oct;8(5):
pubmed: 29177105
Liver Int. 2020 Oct;40(10):2417-2426
pubmed: 32558189
Adv Nutr. 2016 Jan 15;7(1):5-13
pubmed: 26773011
Cells. 2021 Oct 02;10(10):
pubmed: 34685614
Nat Rev Endocrinol. 2014 Jan;10(1):13-23
pubmed: 24146033
J Gastroenterol. 2011 Jan;46 Suppl 1:63-9
pubmed: 20844903
Diabetologia. 2011 Mar;54(3):641-7
pubmed: 21153530
Mediators Inflamm. 2010;2010:837419
pubmed: 20300479
Ann Hepatol. 2017 May - Jun 2017;16(3):382-394
pubmed: 28425408
World J Hepatol. 2014 May 27;6(5):274-83
pubmed: 24868321
Obesity (Silver Spring). 2015 Feb;23(2):468-74
pubmed: 25521620
J Clin Endocrinol Metab. 2022 May 17;107(6):e2309-e2317
pubmed: 35238939
World J Gastroenterol. 2012 Jan 21;18(3):237-43
pubmed: 22294826
Front Endocrinol (Lausanne). 2021 Mar 29;12:641446
pubmed: 33854482
FASEB J. 2007 Aug;21(10):2622-32
pubmed: 17456783
Dig Liver Dis. 2009 Sep;41(9):665-70
pubmed: 19201267
Front Nutr. 2021 Feb 22;8:633703
pubmed: 33693023
Eur J Obstet Gynecol Reprod Biol X. 2019 Jun 08;3:100060
pubmed: 31403134
Eur J Clin Invest. 2009 Aug;39(8):631-48
pubmed: 19496803
Best Pract Res Clin Endocrinol Metab. 2017 Dec;31(6):521-533
pubmed: 29224665
World J Gastroenterol. 2015 Nov 7;21(41):11522-41
pubmed: 26556984
World J Gastroenterol. 2014 Mar 14;20(10):2515-32
pubmed: 24627588
Nutrients. 2020 Sep 03;12(9):
pubmed: 32899228
Adv Ther. 2017 Jun;34(6):1291-1326
pubmed: 28526997
Ann Epidemiol. 2013 Mar;23(3):119-23
pubmed: 23298439
Nutr Clin Pract. 2020 Feb;35(1):72-84
pubmed: 31840865
JGH Open. 2021 Feb 25;5(4):434-445
pubmed: 33860093
Endocr Rev. 1998 Feb;19(1):55-79
pubmed: 9494780
Diabetol Metab Syndr. 2021 Aug 26;13(1):90
pubmed: 34446090
Nutrients. 2022 Apr 23;14(9):
pubmed: 35565740
J Pathol. 2017 Jan;241(1):36-44
pubmed: 27757953
Curr Hepatol Rep. 2019 Dec;18(4):425-432
pubmed: 32523869
Int J Obes (Lond). 2015 Oct;39(10):1539-47
pubmed: 26032810
Biomed Res Int. 2015;2015:131528
pubmed: 25973422
Hepatology. 2021 Dec;74(6):2988-2997
pubmed: 34192367
Clin Gastroenterol Hepatol. 2021 Jun;19(6):1267-1274.e1
pubmed: 33010412
Cell Metab. 2010 Nov 3;12(5):483-95
pubmed: 21035759
Growth Horm IGF Res. 2018 Oct - Dec;42-43:58-65
pubmed: 30227383
J Hepatol. 2019 Jan;70(1):126-132
pubmed: 30392752
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Proc Soc Exp Biol Med. 2000 Apr;223(4):344-51
pubmed: 10721003
Ann Hepatol. 2010 Oct-Dec;9(4):402-9
pubmed: 21057159
J Clin Endocrinol Metab. 2006 May;91(5):1741-7
pubmed: 16492691
Horm Metab Res. 2021 Feb;53(2):100-104
pubmed: 33513642